Reproducibility of synovial fluid examination for crystals.

Area of Science:

• Rheumatology
• Clinical Pathology
• Laboratory Medicine

Background:

• Synovial fluid crystal analysis is crucial for diagnosing crystal-induced arthropathies.
• Accurate identification of crystals like calcium pyrophosphate dihydrate (CPPD) and monosodium urate monohydrate (urate) is essential for patient management.
• Quality assurance is vital to ensure reliable diagnostic testing in clinical laboratories.

Purpose of the Study:

• To assess the quality of synovial fluid crystal examination across six teaching hospitals in Sydney.
• To identify variations in diagnostic accuracy and identify potential areas for improvement in laboratory practices.
• To evaluate the performance of laboratories in identifying various crystal types, including CPPD and urate crystals.

Main Methods:

• A quality assurance survey was conducted involving six teaching hospital laboratories.
• Laboratories examined 12 standardized synovial fluid samples containing no crystals, betamethasone, CPPD, or urate crystals.
• Performance was evaluated based on the accuracy of crystal identification and the rate of false positive/negative results.

Main Results:

• Four out of six laboratories performed well, correctly identifying 10 or more out of 12 samples.
• Two laboratories demonstrated poor performance, with accuracy at 50% or less.
• False positive crystal identifications occurred in 8/72 samples, exclusively from the two underperforming laboratories. CPPD and urate crystals were missed in 29% and 21% of samples, respectively.

Conclusions:

• The standard of synovial fluid crystal examination in Sydney teaching hospitals is inconsistent.
• Two laboratories exhibited unsatisfactory performance, characterized by missed crystal identifications and false positive reports.
• There is a need for improved quality control and standardization of synovial fluid analysis to ensure accurate diagnosis and patient care.